Literature DB >> 13686510

Observations on the action of Sernyl-a new psychotropic drug.

T A BAN, J J LOHRENZ, H E LEHMANN.   

Abstract

Entities:  

Keywords:  ANESTHETICS/therapy; PSYCHOPHARMACOLOGY

Mesh：

Substances：

Year:  1961        PMID： 13686510     DOI： 10.1177/070674376100600307

Source DB:  PubMed          Journal:  Can Psychiatr Assoc J        ISSN： 0008-4824


× No keyword cloud information.
  7 in total

Review 1.  Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.

Authors:  R W McCarley; M A Niznikiewicz; D F Salisbury; P G Nestor; B F O'Donnell; Y Hirayasu; H Grunze; R W Greene; M E Shenton
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 2.  [REVIEW OF PSYCHODYSLEPTICS: I. CLASSIFICATION OF PSYCHODYSLEPTICS].

Authors:  P RAJOTTE
Journal:  Can Med Assoc J       Date:  1964-08-08       Impact factor: 8.262

Review 3.  [PSYCHODYSLEPTIC DRUGS. II. SOME PROBLEMS RELATED TO THEIR USE].

Authors:  P RAJOTTE
Journal:  Can Med Assoc J       Date:  1964-08-15       Impact factor: 8.262

4.  Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study.

Authors:  Cynthia H Y Fu; Kathryn M Abel; Matthew P G Allin; David Gasston; Sergi G Costafreda; John Suckling; Steve C R Williams; Philip K McGuire
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

5.  Phencyclidine and chemical "stroking".

Authors:  R L Alexander
Journal:  J Natl Med Assoc       Date:  1980-09       Impact factor: 1.798

6.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

Review 7.  Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?

Authors:  Alexei M Bygrave; Kasyoka Kilonzo; Dimitri M Kullmann; David M Bannerman; Dennis Kätzel
Journal:  Front Psychiatry       Date:  2019-11-21       Impact factor: 4.157
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.